Clinical Trials Directory

Trials / Completed

CompletedNCT01405300

The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Penn State University · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Pilot study data have demonstrated that peanuts ameliorate the postprandial glucose and insulin response when incorporated into an acute high fat/high glucose meal. However, it is unclear whether acute consumption of peanuts can also influence vascular function. This study will therefore evaluate the effects of acute peanut consumption on vascular function, glycemic control, and plasma lipids. The hypothesis is that that addition of peanuts to a high fat/high glucose meal will reduce the production of triglycerides, glucose, and improve endothelial function as measured by flow-mediated dilation (FMD).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTControl34.8 g dextrose, 150 g heavy whipping cream, 39g chocolate syrup, 15 g sunflower oil, 22 g safflower oil, 27 g powdered egg whites, 9.6 g of fiber supplement, water and crushed ice. It will deliver \~1200 kcal.
DIETARY_SUPPLEMENTPeanut34.8 g dextrose. 137 g heavy whipping cream, 39g chocolate syrup + 3 oz peanuts with skin. It will deliver \~1200 kcal.

Timeline

Start date
2011-08-01
Primary completion
2014-05-01
Completion
2014-06-01
First posted
2011-07-29
Last updated
2023-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01405300. Inclusion in this directory is not an endorsement.